ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM NEW
Total 13F shares
12,547,614
Share change
+6,752,935
Total reported value
$12,776,470
Put/Call ratio
125%
Price per share
$0.94
Number of holders
50
Value change
+$6,594,245
Number of buys
27
Number of sells
9

Institutional Holders of ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) as of Q1 2021

As of 31 Mar 2021 ADAMIS PHARMACEUTICALS CORP - COM NEW (ADMP) had 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 12,547,614 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, MILLENNIUM MANAGEMENT LLC, Virtu Financial LLC, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, and MORGAN STANLEY.
This table shows 50 institutional shareholders of the security as of 31 Mar 2021.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.